Carton Labeling (Box Labeling)
Nalbuphine Hci Injection, Solution
Product Images NDC 51662-1418
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hci (NDC 51662-1418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Boxed Warning (Boxed Warning)
This text is a warning for the potential life-threatening side effects associated with the use of Nalbuphine Hydrochloride Injection, which can lead to respiratory depression, especially when used with other opioids or central nervous system depressants such as benzodiazepines or alcohol. It is recommended to limit dosages and durations to the required minimum and monitor patients for signs and symptoms of respiratory depression and sedation. The concomitant prescribing of nalbuphine hydrochloride and benzodiazepines or other CNS depressants should be reserved for patients for whom alternative treatment options are inadequate.*
How Supplied (How Supplied)
This is a list of different pharmaceutical products with their packaging details and concentration of the solution in each. The products are available in single-dose ampuls and multiple-dose fliptop vials with varying concentrations of 10 mg/mL and 20 mg/mL. The multiple-dose fliptop vials come in cases of 25 with a concentration of either 100mg/10mL or 200mg/10mL.*
Logo (Logo)
Serialized Carton Labeling (Serialized Box Labeling)
Structure (Structure)
Vial Labeling (Vial Labeling)
This is a description of a multiple-dose medication containing nalbuphine HCI, a drug used for pain relief. Each mL of the medication contains 20mg of nalbuphine HCI, as well as buffers, preservatives, and saline solution to adjust tonicity. The medication is sterile and nonpyrogenic, and may contain NaOH and/or HCI to adjust pH. Dosage information is found in the insert. The medication should be stored at 20 to 25°C (68 to 77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
